SL
SVB Leerink Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
176
Agios Pharmaceuticals
AGIO
$2.13B
|
AB
Andrew Berens
| $36.72 | $37 |
1%
upside
| Outperform |
5 Aug ‘22
3 years ago |
|
177
Jazz Pharmaceuticals
JAZZ
$7.86B
|
MG
Marc Goodman
| $129.52 | $210 |
62%
upside
| Outperform |
4 Aug ‘22
3 years ago |
|
178
BioNTech
BNTX
$24.8B
|
DG
Daina Graybosch
| $102.96 | $224 |
118%
upside
| Outperform |
29 Jul ‘22
3 years ago |
|
179
Teladoc Health
TDOC
$1.38B
|
SDD
Stephanie Davis Demko
| $7.83 | $34 |
334%
upside
| Market Perform |
28 Jul ‘22
3 years ago |
|
180
Nkarta
NKTX
$154M
|
DG
Daina Graybosch
| $2.17 | $30 |
1,282%
upside
| Outperform |
18 Jul ‘22
3 years ago |
|
181
IQVIA
IQV
$31.8B
|
JZ
Joy Zhang
| $187.15 | $256 |
37%
upside
| Outperform |
15 Jul ‘22
3 years ago |
|
182
AC Immune
ACIU
$221M
|
MG
Marc Goodman
| $2.20 | $10 |
355%
upside
| Outperform |
11 Jul ‘22
3 years ago |
|
183
89bio
ETNB
$1.27B
|
TS
Thomas Smith
| $8.57 | $29 |
238%
upside
| Outperform |
11 Jul ‘22
3 years ago |
|
184
HealthEquity
HQY
$7.95B
|
SD
Stephanie Davis
| $92.22 | $76 |
18%
downside
| Outperform |
7 Jun ‘22
3 years ago |
|
185
Immatics
IMTX
$712M
|
JC
Jonathan Chang
| $5.86 | $26 |
344%
upside
| Outperform |
3 Jun ‘22
3 years ago |
|
186
Eledon Pharmaceuticals
ELDN
$159M
|
TS
Thomas Smith
| $2.65 | $26 |
881%
upside
| Outperform |
1 Jun ‘22
3 years ago |
|
187
Crinetics Pharmaceuticals
CRNX
$3.36B
|
JS
Joseph Schwartz
| $35.64 | $39 |
9%
upside
| Outperform |
26 May ‘22
3 years ago |
|
188
HilleVax
HLVX
$105M
|
DR
David Risinger
| $2.10 | $30 |
1,329%
upside
| Outperform |
24 May ‘22
3 years ago |
|
189
Doximity
DOCS
$13.1B
|
SD
Stephanie Davis
| $70.09 | $67 |
4%
downside
| Outperform |
18 May ‘22
3 years ago |
|
190
Cullinan Oncology
CGEM
$405M
|
AB
Andrew Berens
| $6.86 | $25 |
264%
upside
| Outperform |
13 May ‘22
3 years ago |
|
191
InflaRx
IFRX
$107M
|
JS
Joseph Schwartz
| $1.58 | $4 |
153%
upside
| Outperform |
12 May ‘22
3 years ago |
|
192
Caribou Biosciences
CRBU
$171M
|
MF
Mani Foroohar
| $1.84 | $34 |
1,748%
upside
| Outperform |
12 May ‘22
3 years ago |
|
193
Edgewise Therapeutics
EWTX
$1.57B
|
JS
Joseph Schwartz
| $14.90 | $30 |
101%
upside
| Outperform |
12 May ‘22
3 years ago |
|
194
Zai Lab
ZLAB
$3.47B
|
JC
Jonathan Chang
| $31.20 | $95 |
204%
upside
| Outperform |
11 May ‘22
3 years ago |
|
195
Avidity Biosciences
RNA
$6.33B
|
JS
Joseph Schwartz
| $49.17 | $50 |
2%
upside
| Outperform |
11 May ‘22
3 years ago |
|
196
Werewolf Therapeutics
HOWL
$61.3M
|
DG
Daina Graybosch
| $1.34 | $17 |
1,169%
upside
| Outperform |
11 May ‘22
3 years ago |
|
|
ADAP
197
Adaptimmune Therapeutics
ADAP
$11.7M
|
JC
Jonathan Chang
| $0.0440 | $3 |
6,718%
upside
| Market Perform |
9 May ‘22
3 years ago |
|
198
RxSight
RXST
$360M
|
DA
Danielle Antalffy
| $8.81 | $14 |
59%
upside
| Outperform |
6 May ‘22
3 years ago |
|
199
Insulet
PODD
$24.5B
|
DA
Danielle Antalffy
| $347.70 | $280 |
19%
downside
| Outperform |
6 May ‘22
3 years ago |
|
200
Outset Medical
OM
$245M
|
DA
Danielle Antalffy
| $13.78 | $825 |
5,887%
upside
| Outperform |
5 May ‘22
3 years ago |
|